Exploring the mid-term impact of telemonitoring in Parkinson's disease: insights from adoption into clinical practice.

IF 3.4 Q3 CLINICAL NEUROLOGY

Neurodegenerative disease management Pub Date : 2025-10-15 DOI:10.1080/17582024.2025.2562754

Foivos S Kanellos, Eleni Kosmidi, Georgios Rigas, Ermioni Petkou, Yannis V Simos, Lampros Lakkas, Dimitrios Peschos, Spyridon Konitsiotis, Konstantinos I Tsamis

{"title":"Exploring the mid-term impact of telemonitoring in Parkinson's disease: insights from adoption into clinical practice.","authors":"Foivos S Kanellos, Eleni Kosmidi, Georgios Rigas, Ermioni Petkou, Yannis V Simos, Lampros Lakkas, Dimitrios Peschos, Spyridon Konitsiotis, Konstantinos I Tsamis","doi":"10.1080/17582024.2025.2562754","DOIUrl":null,"url":null,"abstract":"Background: Routine clinical evaluations offer limited insight into daily variability and disease progression in Parkinson's disease (PD). While wearable devices are increasingly used to improve patient monitoring, evidence of their effectiveness remains scarce.Objective: To assess the efficacy of integrating a telemonitoring system into standard clinical procedures, highlighting its role in enabling efficient, patient-centered treatment adjustments.Methods: Thirty-five PD patients were monitored for 6 months using a telemonitoring device alongside standard care. Disease progression was assessed via MDS-UPDRS part III (UPDRS-p3) and device-reported outcomes (dUPDRS) at baseline and follow-up. Physicians provided feedback on telemedicine utility.Results: UPDRS-p3 scores improved by 1.9-5.63 points. Changes in UPDRS-p3 strongly correlated with dUPDRS (r = 0.82). Sixty-two percent of patients had treatment modifications, 36% of which occurred remotely.Conclusion: Telemonitoring supported clinical decisions, detected subtle symptom changes, and offered valuable insights for improving motor symptoms and patient management.","PeriodicalId":19114,"journal":{"name":"Neurodegenerative disease management","volume":" ","pages":"1-7"},"PeriodicalIF":3.4000,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurodegenerative disease management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17582024.2025.2562754","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Routine clinical evaluations offer limited insight into daily variability and disease progression in Parkinson's disease (PD). While wearable devices are increasingly used to improve patient monitoring, evidence of their effectiveness remains scarce.

Objective: To assess the efficacy of integrating a telemonitoring system into standard clinical procedures, highlighting its role in enabling efficient, patient-centered treatment adjustments.

Methods: Thirty-five PD patients were monitored for 6 months using a telemonitoring device alongside standard care. Disease progression was assessed via MDS-UPDRS part III (UPDRS-p3) and device-reported outcomes (dUPDRS) at baseline and follow-up. Physicians provided feedback on telemedicine utility.

Results: UPDRS-p3 scores improved by 1.9-5.63 points. Changes in UPDRS-p3 strongly correlated with dUPDRS (r = 0.82). Sixty-two percent of patients had treatment modifications, 36% of which occurred remotely.

Conclusion: Telemonitoring supported clinical decisions, detected subtle symptom changes, and offered valuable insights for improving motor symptoms and patient management.

查看原文本刊更多论文

探索远程监控在帕金森病中的中期影响：从采用到临床实践的见解。

背景：常规临床评估对帕金森病（PD）的日常变异性和疾病进展提供了有限的见解。虽然可穿戴设备越来越多地用于改善患者监测，但其有效性的证据仍然很少。目的：评估将远程监护系统整合到标准临床程序中的效果，强调其在实现高效、以患者为中心的治疗调整中的作用。方法：对35例PD患者进行为期6个月的远程监护。通过MDS-UPDRS第三部分（UPDRS-p3）和设备报告结果（dUPDRS）在基线和随访时评估疾病进展。医生提供了对远程医疗效用的反馈。结果：UPDRS-p3评分提高1.9 ~ 5.63分。UPDRS-p3的变化与dUPDRS呈强相关（r = 0.82）。62%的患者进行了治疗调整，其中36%的患者进行了远程治疗。结论：远程监测支持临床决策，发现细微的症状变化，并为改善运动症状和患者管理提供有价值的见解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurodegenerative disease management CLINICAL NEUROLOGY-

CiteScore

4.30

自引率

0.00%

发文量